In the study published in JAMA Internal Medicine , we compared weight loss outcomes for patients taking semaglutide and tirzepatide approved by the FDA for treating type 2 diabetes (Ozempic and Mounjaro, respectively)
Though not FDA-approved solely for weight loss, Ozempic has been used off-label for this purpose, with potential changes in facial aesthetics that can be managed through cosmetic procedures, facial exercises, and skincare routines
However, as we delve deeper into the science of this powerful compound, it's essential to consider its implications for kidney function, particularly given the kidneys' unique metabolic environment
15/ This led researchers to suspect there was something in the venom effecting insulin
For data analysis, we used R, and for data visualization, Prim Plus (version 84) was utilized
A: While rare, some users report mild gastroparesis symptoms